0001209191-19-043685.txt : 20190730
0001209191-19-043685.hdr.sgml : 20190730
20190730164846
ACCESSION NUMBER: 0001209191-19-043685
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190726
FILED AS OF DATE: 20190730
DATE AS OF CHANGE: 20190730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gilbert Halley E
CENTRAL INDEX KEY: 0001601360
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34620
FILM NUMBER: 19986101
MAIL ADDRESS:
STREET 1: C/O IRONWOOD PHARMACEUTICALS, INC.
STREET 2: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001446847
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043404176
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-07-26
0
0001446847
IRONWOOD PHARMACEUTICALS INC
IRWD
0001601360
Gilbert Halley E
C/O IRONWOOD PHARMACEUTICALS, INC.
301 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Admin Officer & SVP
Class A Common Stock
2019-07-26
4
M
0
20000
4.88
A
260169
D
Class A Common Stock
2019-07-26
4
S
0
20000
10.00
D
240169
D
Employee Stock Option (Right to Buy)
4.88
2019-07-26
4
M
0
20000
4.88
D
2019-07-28
Class A Common Stock
20000
22472
D
The reporting person acquired 1,929 shares of Class A common stock under the issuer's employee stock purchase plan on June 28, 2019.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.80 to $10.09, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The option vested as to 20,000 shares of Class A Common Stock upon the issuer's achievement of a commercial milestone on January 4, 2017. The remainder of the option expired on July 28, 2019.
/s/ Conor Kilroy, Attorney-in-Fact
2019-07-30